← Back to Search

Primary Care Practices for Coronavirus (CATCH-UP Trial)

N/A

Waitlist Available

Led By Judith A James, MD, PhD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 12

Awards & highlights

CATCH-UP Trial Summary

This trial will help Oklahoma primary care practices implement guidelines-based testing and patient education about COVID-19, and deploy mobile testing sites to increase the efficiency of state-wide testing by Oklahoma's public health authorities.

Eligible Conditions

Coronavirus

CATCH-UP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Barriers to SARS-CoV-2 Testing (Practices)

Change in SARS-CoV-2 Test Positivity Rate (Community Sites)

Change in SARS-CoV-2 Testing Rate (Practices)

Secondary outcome measures

COVID-19 Referrals

Change in Influenza Vaccination Rate (NQF #41)

Change in Pneumococcal Vaccination Rate (NQF #127)

+1 more

CATCH-UP Trial Design

1Treatment groups

Experimental Treatment

Group I: Primary Care PracticesExperimental Treatment1 Intervention

A practice-based implementation study will be conducted with 50 practices, with baseline data collection, and overlapping with interim measurements of care quality and process outcomes, followed by a final data collection at the end of the intervention (including baseline measures plus semi-structured interviews. The practice based approach to increasing testing will be compared to a community-based approach using mobile-setting to increase testing. Additional, non-clinical trial components of this study include patient surveys to understand facilitators and barriers to SARS-CoV-2 testing and identification of legal/ethical, socioeconomic, and behavioral implications of increased testing. Patients are not direct subjects in this part of the study. Intervention will target practices and practice members.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of General Medical Sciences (NIGMS)NIH

268 Previous Clinical Trials

248,436 Total Patients Enrolled

University of OklahomaLead Sponsor

455 Previous Clinical Trials

97,286 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,264 Total Patients Enrolled

Media Library

Primary Care Practices Clinical Trial Eligibility Overview. Trial Name: NCT04870307 — N/A

Coronavirus Research Study Groups: Primary Care Practices

Coronavirus Clinical Trial 2023: Primary Care Practices Highlights & Side Effects. Trial Name: NCT04870307 — N/A

Primary Care Practices 2023 Treatment Timeline for Medical Study. Trial Name: NCT04870307 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the central goals of this scientific experiment?

"This medical trial will evaluate the SARS-CoV-2 Test Positivity Rate in multiple communities over a 12 month period. Additionally, it seeks to measure changes in Zoster Vaccination Rates among those aged 50 and older, alterations of the Pneumococcal Vaccination Rates for seniors 65 or above, as well as track COVID-19 Referrals generated by this study."

Answered by AI

Are there any remaining opportunities to partake in this research endeavor?

"From the data hosted on clinicaltrials.gov, it appears that this particular medical trial is not currently recruiting patients. The study was initially posted to the website in September of 2020 and last updated on May 25th 2022; however, there are 1040 other trials actively looking for participants at this time."

Answered by AI